Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: Endostar;   Drug: DDP
Sponsor:   First Affiliated Hospital of Guangxi Medical University
Not yet recruiting - verified September 2016

http://ift.tt/2d1RKiR